Literature DB >> 23430907

Report of a Large Brazilian Family With a Very Attenuated Form of Hunter Syndrome (MPS II).

C R D C Quaio1, H Grinberg, M L C Vieira, A C Paula, G N Leal, I Gomy, S Leistner-Segal, R Giugliani, D R Bertola, C A Kim.   

Abstract

Hunter syndrome, or Mucopolysaccharidosis type II (MPS II), is a rare X-linked recessive disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase (IDS). The phenotypic spectrum varies from severe to attenuated clinical forms. We report a large Brazilian family with 16 affected individuals exhibiting a very attenuated form of MPS II. Fourteen female carriers were also identified. Twelve affected male patients, whose ages ranged from 1 to 35 years, were examined. Molecular analysis showed a novel missense mutation (p.A77D) in the IDS gene, confirming the diagnosis. Nine of the family members presented some degree of heart damage, though only the proband became symptomatic and required heart transplantation. One 19-year-old adult and 1-year-old twin boys each had a normal echocardiogram. Short stature was found in two adults while macrocephaly was found in one; the remaining adults had anthropometric measures within normal range. All affected adults had normal cognitive development and were able to perform normal daily activities, except one who had mild learning disability. Two patients died due to natural causes beyond 70 years of age. The female carriers did not present any signs of disease. In this large family with a mild form of MPS II and variable degree of clinical manifestations, it is noteworthy that several affected individuals have remained asymptomatic even at advanced age and even without enzyme replacement therapy.

Entities:  

Year:  2011        PMID: 23430907      PMCID: PMC3509904          DOI: 10.1007/8904_2011_90

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  7 in total

1.  A case of the Hunter syndrome with progeny.

Authors:  N DiFerrante; B L Nichols
Journal:  Johns Hopkins Med J       Date:  1972-05

2.  Hunter's syndrome: a study in airway obstruction.

Authors:  C T Sasaki; R Ruiz; R Gaito; J A Kirchner; B Seshi
Journal:  Laryngoscope       Date:  1987-03       Impact factor: 3.325

Review 3.  Multidisciplinary management of Hunter syndrome.

Authors:  Joseph Muenzer; M Beck; C M Eng; M L Escolar; R Giugliani; N H Guffon; P Harmatz; W Kamin; C Kampmann; S T Koseoglu; B Link; R A Martin; D W Molter; M V Muñoz Rojas; J W Ogilvie; R Parini; U Ramaswami; M Scarpa; I V Schwartz; R E Wood; E Wraith
Journal:  Pediatrics       Date:  2009-11-09       Impact factor: 7.124

4.  Initial report from the Hunter Outcome Survey.

Authors:  J Edmond Wraith; Michael Beck; Roberto Giugliani; Joe Clarke; Rick Martin; Joseph Muenzer
Journal:  Genet Med       Date:  2008-07       Impact factor: 8.822

Review 5.  Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).

Authors:  Rick Martin; Michael Beck; Christine Eng; Roberto Giugliani; Paul Harmatz; Verónica Muñoz; Joseph Muenzer
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

6.  Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome.

Authors:  Joseph Muenzer; Michael Beck; Christine M Eng; Roberto Giugliani; Paul Harmatz; Rick Martin; Uma Ramaswami; Ashok Vellodi; James E Wraith; Maureen Cleary; Muge Gucsavas-Calikoglu; Ana Cristina Puga; Marwan Shinawi; Birgit Ulbrich; Suresh Vijayaraghavan; Susanne Wendt; Anne Marie Conway; Alexandra Rossi; David A H Whiteman; Alan Kimura
Journal:  Genet Med       Date:  2011-02       Impact factor: 8.822

Review 7.  Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.

Authors:  J Edmond Wraith; Maurizio Scarpa; Michael Beck; Olaf A Bodamer; Linda De Meirleir; Nathalie Guffon; Allan Meldgaard Lund; Gunilla Malm; Ans T Van der Ploeg; Jiri Zeman
Journal:  Eur J Pediatr       Date:  2007-11-23       Impact factor: 3.183

  7 in total
  2 in total

1.  A New Mutation in IDS Gene Causing Hunter Syndrome: A Case Report.

Authors:  Caio Perez Gomes; Maryana Mara Marins; Fabiana Louise Motta; Sandra Obikawa Kyosen; Marco Antonio Curiati; Vânia D'Almeida; Ana Maria Martins; João Bosco Pesquero
Journal:  Front Genet       Date:  2020-03-18       Impact factor: 4.599

2.  Intrafamilial variability in the clinical manifestations of mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS).

Authors:  Can Ficicioglu; Roberto Giugliani; Paul Harmatz; Nancy J Mendelsohn; Virginie Jego; Rossella Parini
Journal:  Am J Med Genet A       Date:  2017-12-06       Impact factor: 2.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.